← Back to Search

IBS-C for Irritable Bowel Syndrome

N/A
Waitlist Available
Led By Christopher N Andrews
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 5 days of primary measures
Awards & highlights

Study Summary

This trial will test a new pill that aims to improve accuracy of taking a sample from the small bowel, with the goal of helping those with IBS-C and IBS-D.

Eligible Conditions
  • Proof of Concept
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 5 days of primary measures
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 5 days of primary measures for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Bacterial composition

Trial Design

3Treatment groups
Active Control
Group I: IBS-CActive Control3 Interventions
Participant diagnosed with Irritable Bowel Syndrome, constipation predominant, confirmed by study doctors using Rome IV criteria.
Group II: Healthy ControlActive Control3 Interventions
Participant with no ongoing medical conditions affecting GI health.
Group III: IBS-DActive Control3 Interventions
Participant diagnosed with Irritable Bowel Syndrome, diarrhea predominant, confirmed by study doctors using Rome IV criteria.

Find a Location

Who is running the clinical trial?

Nimble Science Ltd.Industry Sponsor
6 Previous Clinical Trials
455 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
150 Patients Enrolled for Irritable Bowel Syndrome
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,124 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
79 Patients Enrolled for Irritable Bowel Syndrome
Christopher N AndrewsPrincipal InvestigatorCumming School of Medicine, University of Calgary

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Cumming School of Medicine, University of Calgary
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule
2021. "Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04094558.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top